CA1264035A - Particules therapeutiques - Google Patents

Particules therapeutiques

Info

Publication number
CA1264035A
CA1264035A CA000504499A CA504499A CA1264035A CA 1264035 A CA1264035 A CA 1264035A CA 000504499 A CA000504499 A CA 000504499A CA 504499 A CA504499 A CA 504499A CA 1264035 A CA1264035 A CA 1264035A
Authority
CA
Canada
Prior art keywords
therapeutic active
coating
lipid
particles according
therapeutic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA000504499A
Other languages
English (en)
Inventor
Paul D. Leis, Jr.
Ghebre E. Tzeghai
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Procter and Gamble Co
Original Assignee
Procter and Gamble Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter and Gamble Co filed Critical Procter and Gamble Co
Application granted granted Critical
Publication of CA1264035A publication Critical patent/CA1264035A/fr
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5015—Organic compounds, e.g. fats, sugars

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
CA000504499A 1985-03-21 1986-03-19 Particules therapeutiques Expired CA1264035A (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/714,606 US4755387A (en) 1985-03-21 1985-03-21 Therapeutic particles
US714,606 1985-03-21

Publications (1)

Publication Number Publication Date
CA1264035A true CA1264035A (fr) 1989-12-27

Family

ID=24870739

Family Applications (1)

Application Number Title Priority Date Filing Date
CA000504499A Expired CA1264035A (fr) 1985-03-21 1986-03-19 Particules therapeutiques

Country Status (10)

Country Link
US (1) US4755387A (fr)
EP (1) EP0195476B1 (fr)
JP (1) JPS61275211A (fr)
AU (1) AU599020B2 (fr)
CA (1) CA1264035A (fr)
DE (1) DE3674440D1 (fr)
DK (1) DK133286A (fr)
HK (1) HK54293A (fr)
IE (1) IE58439B1 (fr)
SG (1) SG32993G (fr)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8730011D0 (en) * 1987-12-23 1988-02-03 Smithkline Dauelsberg Pharmaceutical compositions
DE3838094A1 (de) * 1988-11-10 1990-05-17 Nordmark Arzneimittel Gmbh Feste pharmazeutische retardform
LU87410A1 (fr) * 1988-12-20 1990-07-10 Cird Composition cosmetique ou pharmaceutique contenant des microspheres de polymeres ou de corps gras chargees d'au moins un produit actif
JP2936574B2 (ja) * 1989-03-07 1999-08-23 大正製薬株式会社 鎮痛剤
US5213810A (en) * 1990-03-30 1993-05-25 American Cyanamid Company Stable compositions for parenteral administration and method of making same
IE65045B1 (en) * 1990-04-28 1995-10-04 Takeda Chemical Industries Ltd Granulated preparations and method of producing the same
IE61651B1 (en) * 1990-07-04 1994-11-16 Zambon Spa Programmed release oral solid pharmaceutical dosage form
JP2948317B2 (ja) * 1991-05-28 1999-09-13 マクニール―ピーピーシー・インコーポレーテツド 噛める薬物投与用組成物
US5380535A (en) * 1991-05-28 1995-01-10 Geyer; Robert P. Chewable drug-delivery compositions and methods for preparing the same
EP0616799B1 (fr) * 1993-03-24 2000-05-03 COLLABORATIVE LABORATORIES Inc. Système d'administration cosmétique pour l'acide salicylique et méthode de préparation
US5447354A (en) * 1993-11-10 1995-09-05 Delp; Melvin D. Children's wagon top conversion assembly
US5891476A (en) * 1997-12-22 1999-04-06 Reo; Joe P. Tastemasked pharmaceutical system
DE69924735T2 (de) * 1998-07-28 2006-01-19 Tanabe Seiyaku Co., Ltd. Zur wirkstoffabgabe an zielorten im darm fähige zubereitung
AU5476599A (en) * 1998-09-08 2000-03-27 Biovail International Ltd. Encapsulation of caffeine
WO2003097013A1 (fr) * 2002-05-16 2003-11-27 Tecnofarma Corp. Revetement monocouche pour composes pharmaceutiques en poudre
FR2845289B1 (fr) 2002-10-04 2004-12-03 Ethypharm Sa Spheroides, procede de preparation et compositions pharmaceutiques.
US20060204613A1 (en) * 2005-02-18 2006-09-14 Castro Armando J Chewing gum containing flavor delivery systems
US20060286200A1 (en) * 2005-04-18 2006-12-21 Castro Armando J Confections containing flavor delivery systems
ITPD20070049A1 (it) * 2007-02-14 2008-08-15 Sila S R L Prodotto a base di acido linoleico coniugato e processo per la sua fabbricazione
US20210361581A1 (en) * 2018-10-22 2021-11-25 Ioi Oleo Gmbh Additive for a powder material intended for compaction into shaped bodies

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2793979A (en) * 1953-03-30 1957-05-28 Smith Kline French Lab Method of making a sustained release pharmaceutical tablet and product of the method
US2921883A (en) * 1957-05-03 1960-01-19 Smith Kline French Lab Novel coating material for medicaments
DE1080265B (de) * 1958-09-30 1960-04-21 Bayer Ag Verfahren zur Herstellung von oral anzuwendenden Arzneimittel-zubereitungen mit protrahierter Wirkung aus Wirkstoffen und Schutzstoffen
US3108046A (en) * 1960-11-25 1963-10-22 Smith Kline French Lab Method of preparing high dosage sustained release tablet and product of this method
US3146167A (en) * 1961-10-05 1964-08-25 Smith Kline French Lab Method of preparing sustained release pellets and products thereof
US3147187A (en) * 1962-09-10 1964-09-01 Don Hall Lab Sustained release pharmaceutical
BE640616A (fr) * 1962-12-19
GB1443923A (en) * 1972-05-02 1976-07-28 Shepard M Sustained release compositions
US3965256A (en) * 1972-05-16 1976-06-22 Synergistics Slow release pharmaceutical compositions
DE2360796B2 (de) * 1973-12-06 1977-06-02 Edelfettwerke Werner Schlüter, 2000 Hamburg; Glyco Iberica S.A., Gava, Barcelona (Spanien) Vti: Hegel, K.Th., Dr.; Dickel, K., Dipl.-Ing.; Pat.-Anwälte, 2000 Hamburg und 8000 München Arzneimittel mit verzoegerter abgabe des wirkstoffs im darm
FR2287216A1 (fr) * 1974-10-09 1976-05-07 Narcisse Guy Nouvelle forme galenique d'administration de medicaments et medicaments prepares sous cette nouvelle forme
DE2451488B2 (de) * 1974-10-30 1978-11-23 Milkivit-Werke A. Trouw Gmbh, 4054 Nettetal Wiederkäuer-Beifutter
US4182778A (en) * 1978-05-17 1980-01-08 General Foods Corporation Encapsulation of vitamin and mineral nutrients
JPS6042766B2 (ja) * 1978-12-09 1985-09-25 日本化薬株式会社 基剤
DE3024416C2 (de) * 1980-06-28 1982-04-15 Gödecke AG, 1000 Berlin Verfahren zur Herstellung von Arzneimitteln mit retardierter Wirkstoff-Freisetzung
GB8507779D0 (en) * 1985-03-26 1985-05-01 Fujisawa Pharmaceutical Co Drug carrier

Also Published As

Publication number Publication date
HK54293A (en) 1993-06-11
IE58439B1 (en) 1993-09-22
DK133286A (da) 1986-09-22
SG32993G (en) 1993-05-21
DE3674440D1 (de) 1990-10-31
AU599020B2 (en) 1990-07-12
EP0195476B1 (fr) 1990-09-26
DK133286D0 (da) 1986-03-21
EP0195476A2 (fr) 1986-09-24
JPS61275211A (ja) 1986-12-05
US4755387A (en) 1988-07-05
AU5564386A (en) 1987-10-08
EP0195476A3 (en) 1987-05-27
IE860725L (en) 1986-09-21

Similar Documents

Publication Publication Date Title
CA1264035A (fr) Particules therapeutiques
US6436438B1 (en) Tramadol multiple unit formulations
KR0148002B1 (ko) 서방성 제제
US6902742B2 (en) Multiparticulate modified release composition
JP3157182B2 (ja) 一日一回投与のための吸収の制御されたナプロキセン配合物
CA2616806A1 (fr) Traitement avec des inhibiteurs des canaux calciques a base de dihydropyridine et des acides gras omega-3 et produit combine contenant ceux-ci
WO2008115529A1 (fr) Compositions comprenant des acides gras omega-3 et des inhibiteurs de la cetp
US9446002B2 (en) Spheroids and multiparticulate tablets comprising them
AU2006270047A1 (en) Treatment with azetidinone-based cholesterol absorption inhibitors and omega-3 fatty acids and a combination product thereof
CA2672876A1 (fr) Traitement a base d'anti-arythmisants et d'acides gras omega-3 et produit mixte obtenu a partir de ceux-ci
WO1996036319A1 (fr) Forme pharmaceutique destinee a etre liberee dans le colon
JP2006514988A (ja) 医薬組成物
GB2132887A (en) Enteric-coated anti-inflammatory compositions
EP0094123A2 (fr) Granulés thérapeutiques
WO2008088808A1 (fr) Traitement par médicaments anti-inflammatoires non stéroïdiens et acides gras oméga-3, et produit de combinaison de ceux-ci
WO1998022096A1 (fr) Forme galenique pharmaceutique comportant des revetements enteriques polymeres multiples pour administration dans le colon
CA1209042A (fr) Granules therapeutiques
EP0094116A2 (fr) Granulés thérapeutiques
WO2008112227A1 (fr) Traitement par nicorandil et acides gras oméga 3 et produit combinant ceux-ci
WO1998022095A1 (fr) Forme galenique pharmaceutique conçue pour etre administree dans le colon

Legal Events

Date Code Title Description
MKLA Lapsed